126 related articles for article (PubMed ID: 18656352)
1. A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-57) with cytotoxic and apoptotic effects against human cancer cells.
Lou H; Gao Y; Zhai M; Qi Y; Chen L; Lv H; Yu J; Li Y
Bioorg Med Chem Lett; 2008 Aug; 18(16):4633-7. PubMed ID: 18656352
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4.
Wang H; Chen X; Chen Y; Sun L; Li G; Zhai M; Zhai W; Kang Q; Gao Y; Qi Y
Amino Acids; 2013 Feb; 44(2):499-510. PubMed ID: 22802137
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a novel lipid-peptide conjugate for functionalized liposome.
Yagi N; Yano Y; Hatanaka K; Yokoyama Y; Okuno H
Bioorg Med Chem Lett; 2007 May; 17(9):2590-3. PubMed ID: 17317168
[TBL] [Abstract][Full Text] [Related]
5. beta'-Hydroxy-alpha,beta-unsaturated ketones: A new pharmacophore for the design of anticancer drugs. Part 2.
León LG; Carballo RM; Vega-Hernández MC; Miranda PO; Martín VS; Padrón JI; Padrón JM
ChemMedChem; 2008 Nov; 3(11):1740-7. PubMed ID: 18846591
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of Tat (47-58) peptide on human pathogenic fungi.
Jung HJ; Park Y; Hahm KS; Lee DG
Biochem Biophys Res Commun; 2006 Jun; 345(1):222-8. PubMed ID: 16678135
[TBL] [Abstract][Full Text] [Related]
7. A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is pro-apoptogenic.
Baker RD; Howl J; Nicholl ID
Peptides; 2007 Apr; 28(4):731-40. PubMed ID: 17287047
[TBL] [Abstract][Full Text] [Related]
8. Interactions of cell penetrating peptide Tat with model membranes: a biophysical study.
Dennison SR; Baker RD; Nicholl ID; Phoenix DA
Biochem Biophys Res Commun; 2007 Nov; 363(1):178-82. PubMed ID: 17854767
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of intracellular delivery of anti-cancer drugs by the Tat peptide.
Zhao JF; Chen JY; Mi L; Wang PN; Peng Q
Ultrastruct Pathol; 2011 May; 35(3):119-23. PubMed ID: 21405950
[TBL] [Abstract][Full Text] [Related]
10. A novel series of potent cytotoxic agents targeting G2/M phase of the cell cycle and demonstrating cell killing by apoptosis in human breast cancer cells.
Mandal S; Bérubé G; Asselin E; Mohammad I; Richardson VJ; Gupta A; Pramanik SK; Williams AL; Mandal SK
Bioorg Med Chem Lett; 2007 Sep; 17(17):4955-60. PubMed ID: 17596942
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
Rautsi O; Lehmusvaara S; Ketola A; Määttä AM; Wahlfors J; Pellinen R
Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
[TBL] [Abstract][Full Text] [Related]
13. Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice.
Michod D; Annibaldi A; Schaefer S; Dapples C; Rochat B; Widmann C
J Natl Cancer Inst; 2009 Jun; 101(11):828-32. PubMed ID: 19470951
[TBL] [Abstract][Full Text] [Related]
14. Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells.
Sacco E; Metalli D; Spinelli M; Manzoni R; Samalikova M; Grandori R; Morrione A; Traversa S; Alberghina L; Vanoni M
Biotechnol Adv; 2012; 30(1):233-43. PubMed ID: 21620943
[TBL] [Abstract][Full Text] [Related]
15. Effect of transcription peptide inhibitors on HIV-1 replication.
Van Duyne R; Cardenas J; Easley R; Wu W; Kehn-Hall K; Klase Z; Mendez S; Zeng C; Chen H; Saifuddin M; Kashanchi F
Virology; 2008 Jul; 376(2):308-22. PubMed ID: 18455747
[TBL] [Abstract][Full Text] [Related]
16. Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives.
Cordeu L; Cubedo E; Bandrés E; Rebollo A; Sáenz X; Chozas H; Victoria Domínguez M; Echeverría M; Mendivil B; Sanmartin C; Palop JA; Font M; García-Foncillas J
Bioorg Med Chem; 2007 Feb; 15(4):1659-69. PubMed ID: 17204425
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of both mesothelioma cell growth and Cdk4 activity following treatment with a TATp16INK4a peptide.
Frizelle SP; Kratzke MG; Carreon RR; Engel SC; Youngquist L; Klein MA; Fourre L; Shekels LL; Kratzke RA
Anticancer Res; 2008; 28(1A):1-7. PubMed ID: 18383817
[TBL] [Abstract][Full Text] [Related]
18. Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
Rege K; Patel SJ; Megeed Z; Yarmush ML
Cancer Res; 2007 Jul; 67(13):6368-75. PubMed ID: 17616696
[TBL] [Abstract][Full Text] [Related]
19. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection.
Lo SL; Wang S
Biomaterials; 2008 May; 29(15):2408-14. PubMed ID: 18295328
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation.
Ho SY; Chen WC; Chiu HW; Lai CS; Guo HR; Wang YJ
Chem Biol Interact; 2009 May; 179(2-3):304-13. PubMed ID: 19159621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
